NRDC signed License Agreement with Kudos Laboratories for commercialization of anti-diabetic drug Ayush-82


Posted on:17 Mar 2016 09:14:27

NRDC signed License Agreement with Kudos Laboratories for commercialization of anti-diabetic drug Ayush-82
17 March 2016 Current Affairs: The National Research Development Corporation (NRDC) on 16 March 2016 signed a License Agreement with Kudos Laboratories India for commercialization of Ayush-82, an Ayurvedic formulation for prevention and management of diabetes.The agreement will now allow Kudos Laboratories India to commercialize the drug under their trade name with due acknowledgement to Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH, Government of India.Ayush-82 was developed by CCRAS. The CCRAS is an apex organization for research in Ayurveda under the Ministry of AYUSH. Kudos Laboratories India, a 100 years old organization, is engaged in marketing, manufacturing and exports of the widest range of Ayurvedic / Herbal products and range of Cosmetics.The company holds G.M.P & ISO Certifications.


Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs June 2017

27 JUNE
NEWS
26 JUNE
NEWS
24 JUNE
NEWS
23 JUNE
NEWS

Current Affairs May 2017

31 MAY
NEWS
30 MAY
NEWS
29 MAY
NEWS
27 MAY
NEWS

Current Affairs April 2017

29 APRIL
NEWS
28 APRIL
NEWS
27 APRIL
NEWS
26 APRIL
NEWS